Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Pascual-Ramos

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Arthritis Research & Therapy|July 12, 2015
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy mattersIrazú Contreras-Yáñez, Virginia Pascual-Ramos
BMC Musculoskeletal Disorders|July 30, 2017
Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritisIrazú Contreras-Yáñez, Virginia Pascual-Ramos
BMC Musculoskeletal Disorders|December 3, 2013
Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspectiveVirginia Pascual-Ramos, Irazú Contreras-Yáñez
Rheumatology International|October 14, 2019
Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort studyIrazú Contreras-Yáñez, Guillermo Guaracha-Basáñez, Virginia Pascual-Ramos
Arthritis Research & Therapy|February 23, 2021
Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatientsIrazú Contreras-Yáñez, Pilar Lavielle, Patricia Clark, et al.
Plos One|July 23, 2019
Validation of a risk perception questionnaire developed for patients with rheumatoid arthritisIrazú Contreras-Yáñez, Pilar Lavielle, Patricia Clark, et al.
Annals of Hepatology|February 18, 2009
Autoimmune hepatitis with giant-cell transformationJosé Estradas, Virginia Pascual-Ramos, Braulio Martínez, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled studyCésar Sifuentes-Cantú, David Butrón-Hernández, Irazú Contreras-Yáñez, et al.
European Journal of Radiology|April 12, 2011
Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugsIrazú Contreras-Yáñez, Marina Rull-Gabayet, Jorge Vázquez-Lamadrid, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomesRicardo Cabrera-Marroquín, Irazú Contreras-Yáñez, Natasha Alcocer-Castillejos, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Arthritis Research & Therapy|July 12, 2015
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy mattersIrazú Contreras-Yáñez, Virginia Pascual-Ramos
BMC Musculoskeletal Disorders|July 30, 2017
Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritisIrazú Contreras-Yáñez, Virginia Pascual-Ramos
BMC Musculoskeletal Disorders|December 3, 2013
Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspectiveVirginia Pascual-Ramos, Irazú Contreras-Yáñez
Rheumatology International|October 14, 2019
Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort studyIrazú Contreras-Yáñez, Guillermo Guaracha-Basáñez, Virginia Pascual-Ramos
Arthritis Research & Therapy|February 23, 2021
Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatientsIrazú Contreras-Yáñez, Pilar Lavielle, Patricia Clark, et al.
Plos One|July 23, 2019
Validation of a risk perception questionnaire developed for patients with rheumatoid arthritisIrazú Contreras-Yáñez, Pilar Lavielle, Patricia Clark, et al.
Annals of Hepatology|February 18, 2009
Autoimmune hepatitis with giant-cell transformationJosé Estradas, Virginia Pascual-Ramos, Braulio Martínez, et al.
Clinical and Experimental Rheumatology|April 4, 2020
Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled studyCésar Sifuentes-Cantú, David Butrón-Hernández, Irazú Contreras-Yáñez, et al.
European Journal of Radiology|April 12, 2011
Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugsIrazú Contreras-Yáñez, Marina Rull-Gabayet, Jorge Vázquez-Lamadrid, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomesRicardo Cabrera-Marroquín, Irazú Contreras-Yáñez, Natasha Alcocer-Castillejos, et al.
Pageof 12